Cytotoxic T Lymphocytes in Treating Patients With Malignancies With BK and/or JC Virus

Clinical trial NCT02479698 · RECRUITING

Trial details

NCT number: NCT02479698
Sponsor: M.D. Anderson Cancer Center
Status: RECRUITING
Phase: Phase 2
Study type: INTERVENTIONAL

Acquired Immunodeficiency Syndrome BK Virus Infection Human Immunodeficiency Virus JC Virus Infection Malignant Neoplasm Merkel Cell Carcinoma Merkel Cell Polyomavirus Infection Viral Encephalitis

Start date: 2015-07-23
Primary completion: 2027-07-31
Enrollment: 100

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.